欧盟官方标签名称词汇表条目 13508
IMIDAZOLIDINYL UREA
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 5 个有匹配的监管证据:4 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。
已检查的市场
13
有证据的市场
5
证据缺口
8
已解析的标识符
2
已解析的物质身份
CAS:39236-46-9
EC:254-372-6
成分索引记录:
IMIDAZOLIDINYL UREA
化妆品功能: PRESERVATIVE
N,N'-Methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]
清单限制备注: V/27
7 个匹配或报告的名称
IMIDAZOLIDINYL UREAimidureaN,N''-Methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]Imidazolidinyl ureaN,N″-Methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea] (imidazolidinyl urea)3,3’-Bis(1-hydroxymethyl-2,5-dioxoimidazolidin- 4-yl)-1,1’-methylenediurea (“Imidazolidinyl urea”) CAS No. 39236-46-9이미다졸리디닐우레아(3,3'-비스(1-하이드록시메칠-2,5-디옥소이미다졸리딘-4-일)-1,1'메칠렌디우레아)
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 有条件准用清单匹配 | 1打开记录 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 请查看每条关联记录及其确切条件。 |
| Great Britain GB | Permitted list with conditions | 1打开记录 1 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | 请查看每条关联记录及其确切条件。 |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | Permitted list with conditions | 1打开记录 1 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | 请查看每条关联记录及其确切条件。 |
| ASEAN ASEAN | Permitted list with conditions | 1打开记录 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | 请查看每条关联记录及其确切条件。 |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Restricted | 1打开记录 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | 请查看每条关联记录及其确切条件。 |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | 未找到匹配项 | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | 未找到匹配项 | 0 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply. |
没有与此筛选条件匹配的市场行。
匹配的市场记录和条件
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026South Korea
MFDS Notice 2026-19, effective 18 March 2026附件 II–VI 的精确证据
化学身份与性质

CAS 39236-46-9PubChem CID 38258
Imidazolidinyl Urea
Imidurea is a member of ureas. It has a role as an antimicrobial agent. — ChEBI
- IUPAC 名称
- 1-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoylamino]methyl]urea
- 分子式
- C11H16N8O8
- 分子量
- 388.29 g/mol
- 精确质量
- 388.10910950 Da
- XLogP3
- -3.4
- 拓扑极性表面积
- 222.0 Ų
- 氢键供体
- 8
- 氢键受体
- 8
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
IMIDUREAGermall 115Methanebis(N,N'-(5-ureido-2,4-diketotetrahydroimidazole)-N,N-dimethylol)N,N''-Methylenebis(N'-(1-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea)CHEBI:51805N,N''-methylenebis(N'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea)Urea, N,N''-methylenebis(N'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-N',N'''-methanediylbis{1-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea}
另有 16 个已报告名称
imidazolidinylureaN',N'''-methanediylbis(1-(3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)urea)RefChem:148001254-372-63-(4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1-((((4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)carbamoyl)amino)methyl)urea1,1'-Methylenebis(3-(3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)urea)C11H16N8O8Imidurea [NF]IMIDUREA [II]BSPBio_001082Imidurea (NF)Tox21_302325N,N'-Methylenebis[N'-(3-hydroxymethyl-2,5-dioxo-4-imidazolidinyl)urea]3-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1-[({[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoyl}amino)methyl]ureaImidurea, United States Pharmacopeia (USP) Reference StandardImidazolinidyl urea
外部数据库标识符
- ChEBI:CHEBI:51805
- ChEMBL:CHEMBL65433
- EPA DTXSID:DTXSID2040151
- PubMed:31958493
- PubMed:31734321
- PubMed:29743441
- PubMed:27965148
- PubMed:25617811
- PubMed:23178550
- PubMed:22245253
- PubMed:21195160
- PubMed:20541004
- PubMed:15218738
- PubMed:10841789
- PubMed:1146
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定